ALDX - Aldeyra Therapeutics Stock Trading

Addition of 35-Year Pharmaceutical Industry Veteran Augments Board’s Business Development and Commercial Strategy Expertise Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improv...

Oyster Point Pharma ( OYST +4.6% ) is up on average volume in response to positive topline results from a Phase 2 clinical trial, MYSTIC , evaluating lead candidate OC-01 nasal spray for the treatment of dry eye disease. More news on: Oyster Point Pharma, Inc., Kala Pharmaceuticals,...

The first patient has been enrolled in a two-part Phase 3 clinical trial, GUARD , evaluating Aldeyra Therapeutics' (NASDAQ: ALDX ) ADX-2191 for the prevention of proliferative vitreoretinopathy  (PVR), the formation of scar tissue associated with retinal detachment which can threate...